Aurobindo Pharma gets EIR from USFDA; stock surges 15%

The company's share price is trading higher by more than 15% in trade today.

Feb 19, 2020 04:02 IST India Infoline News Service

Aurobindo Pharma informed the exchanges today that it has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAl) status from USFDA for Unit IV, a general injectable formulation manufacturing facility of the Company.

The stock has surged more than 15% in trade today on this news development.

Stock view:
Aurobindo Pharma Ltd is currently trading at Rs575.55 up by Rs75.35 or 15.06% from its previous closing of Rs500.20 on the BSE.
The scrip opened at Rs550.20 and has touched a high and low of Rs594 and Rs550.20 respectively. So far 1,01,55,127 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs29,308.65cr.

Related Story